CASE STUDY / CLEARCALC
UNMC Validates ClearCalc for Clinical Use
ClearCalc is clinic-ready. That’s what the team at the University of Nebraska Medical Center (UNMC) concluded in an abstract at the 2021 AAPM annual meeting after a thorough review of their newly installed secondary calculation software. Using a number of different methods including open fields, patient plans, and comparisons to Eclipse and ion chamber measurements, UNMC completed a full evaluation of ClearCalc prior to using it clinically.
Download the case study to see how secondary plan evaluation can be faster and more accurate with ClearCalc.
“With its ease of use stemming from its integration to Eclipse and validated dose calculation, ClearCalc is a useful clinical tool, providing accuracy and efficiency for independent dose calculations.”
Ease of Use
Consistent Plan Agreement